Headlines
- Pearsanta Inc. Appoints New President
- Christopher Mitton Brings Decades of Expertise to Pearsanta
- Aditxt’s Subsidiary Accelerates Precision Health with New Leadership
Aditxt (NASDAQ:ADTX), a platform dedicated to advancing health innovations, has announced the appointment of Christopher Mitton as President of its majority-owned subsidiary, Pearsanta Inc. Mitton, who will also continue as CEO of MDNA Life Sciences Inc., brings over 20 years of experience in medical diagnostics and leadership.
Mitton’s career highlights include spearheading commercial operations and product commercialization at Cancer Genetics Inc., driving North American expansion for Ipsogen, and managing personalized healthcare at Qiagen. His extensive background in sales and strategic marketing is expected to significantly contribute to Pearsanta’s precision health initiatives.
Amro Albanna, cofounder, chair, and CEO of Aditxt, expressed enthusiasm about Mitton’s appointment, noting that his expertise will be crucial in enhancing Pearsanta’s growth and innovation in the healthcare sector.